160 related articles for article (PubMed ID: 35945083)
61. Radiotherapy for brain metastases from renal cell cancer: should whole-brain radiotherapy be added to stereotactic radiosurgery?: analysis of 88 patients.
Fokas E; Henzel M; Hamm K; Surber G; Kleinert G; Engenhart-Cabillic R
Strahlenther Onkol; 2010 Apr; 186(4):210-7. PubMed ID: 20165820
[TBL] [Abstract][Full Text] [Related]
62. Overall survival after stereotactic radiotherapy or surgical metastasectomy in oligometastatic renal cell carcinoma patients treated at two Swedish centres 2005-2014.
Stenman M; Sinclair G; Paavola P; Wersäll P; Harmenberg U; Lindskog M
Radiother Oncol; 2018 Jun; 127(3):501-506. PubMed ID: 29754859
[TBL] [Abstract][Full Text] [Related]
63. Spontaneous regression of thoracic metastases while progression of brain metastases after stereotactic radiosurgery and stereotactic body radiotherapy for metastatic renal cell carcinoma: abscopal effect prevented by the blood-brain barrier?
Ishiyama H; Teh BS; Ren H; Chiang S; Tann A; Blanco AI; Paulino AC; Amato R
Clin Genitourin Cancer; 2012 Sep; 10(3):196-8. PubMed ID: 22409865
[No Abstract] [Full Text] [Related]
64. Stereotactic Ablative Radiation Therapy (SAbR) Used to Defer Systemic Therapy in Oligometastatic Renal Cell Cancer.
Zhang Y; Schoenhals J; Christie A; Mohamad O; Wang C; Bowman I; Singla N; Hammers H; Courtney K; Bagrodia A; Margulis V; Desai N; Garant A; Choy H; Timmerman R; Brugarolas J; Hannan R
Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):367-375. PubMed ID: 31377159
[TBL] [Abstract][Full Text] [Related]
65. Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma in Non-surgical Candidates: Initial Clinical Experience.
Chang JH; Cheung P; Erler D; Sonier M; Korol R; Chu W
Clin Oncol (R Coll Radiol); 2016 Sep; 28(9):e109-14. PubMed ID: 27131756
[TBL] [Abstract][Full Text] [Related]
66. [Renal Bellini's collecting duct carcinoma: report of a case].
Wang W; Yu GH; Qu GM; Yao WD; Jiang L
Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):631. PubMed ID: 21092594
[No Abstract] [Full Text] [Related]
67. Stereotactic ablative body radiation therapy for primary kidney cancer: a 3-dimensional conformal technique associated with low rates of early toxicity.
Pham D; Thompson A; Kron T; Foroudi F; Kolsky MS; Devereux T; Lim A; Siva S
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1061-8. PubMed ID: 25442039
[TBL] [Abstract][Full Text] [Related]
68. [Metastatic renal cell carcinoma: therapeutic concepts for non-medicinal treatment].
Wiesner C; Haferkamp A
Urologe A; 2011 Jul; 50(7):853-60. PubMed ID: 21678107
[TBL] [Abstract][Full Text] [Related]
69. Predicting the Risk of Developing New Cerebral Lesions After Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy for Brain Metastases from Renal Cell Carcinoma.
Rades D; Dziggel L; Blanck O; Gebauer N; Bartscht T; Schild SE
Anticancer Res; 2018 May; 38(5):2973-2976. PubMed ID: 29715126
[TBL] [Abstract][Full Text] [Related]
70. [The therapeutic potential of ablative radiotherapy for metastatic renal cell cancer: a tumour deemed radiation resistant].
Coucke P; Jánváry Z; Jansen N
Rev Med Liege; 2014; 69 Suppl 1():94-100. PubMed ID: 24822313
[TBL] [Abstract][Full Text] [Related]
71. SBRT in Localized Renal Carcinoma: A Review of the Literature.
DE LA Pinta C; Latorre RG; Fuentes R
Anticancer Res; 2022 Feb; 42(2):667-674. PubMed ID: 35093865
[TBL] [Abstract][Full Text] [Related]
72. Pancreatic metastases from renal cell carcinoma treated with stereotactic body radiation therapy.
Bourlon MT; Amini A; Kavanagh BD; Flaig TW
Oncology (Williston Park); 2014 Nov; 28(11):1008-12. PubMed ID: 25560737
[No Abstract] [Full Text] [Related]
73. [Post-actinic focal liver lesions].
Sparenberg A; Hamm B; Ernst H
Strahlenther Onkol; 1988 May; 164(5):289-91. PubMed ID: 3375983
[No Abstract] [Full Text] [Related]
74. Radiation therapy in the management of brain metastases from renal cell carcinoma.
Doh LS; Amato R; Paulino AC; Teh BS
Oncology (Williston Park); 2006 May; 20(6):603-13; discussion 613, 616, 619-20 passsim. PubMed ID: 16773845
[TBL] [Abstract][Full Text] [Related]
75. Outcomes of stereotactic radiotherapy for cranial and extracranial metastatic renal cell carcinoma: a systematic review.
Kothari G; Foroudi F; Gill S; Corcoran NM; Siva S
Acta Oncol; 2015 Feb; 54(2):148-57. PubMed ID: 25140860
[TBL] [Abstract][Full Text] [Related]
76. Utilization of radiotherapy and stereotactic body radiation therapy for renal cell cancer in the USA.
Haque W; Verma V; Lewis GD; Lo SS; Butler EB; Teh BS
Future Oncol; 2018 Apr; 14(9):819-827. PubMed ID: 29527938
[TBL] [Abstract][Full Text] [Related]
77. Radiosurgery in renal cell carcinoma.
Muacevic A; Wowra B; Kreth FW
J Neurosurg; 2003 Aug; 99(2):441; author reply 441-2. PubMed ID: 12924727
[No Abstract] [Full Text] [Related]
78. Safety and Efficacy of Stereotactic Ablative Radiation Therapy for Renal Cell Carcinoma Extracranial Metastases.
Wang CJ; Christie A; Lin MH; Jung M; Weix D; Huelsmann L; Kuhn K; Meyer J; Desai N; Kim DWN; Pedrosa I; Margulis V; Cadeddu J; Sagalowsky A; Gahan J; Laine A; Xie XJ; Choy H; Brugarolas J; Timmerman R; Hannan R
Int J Radiat Oncol Biol Phys; 2017 May; 98(1):91-100. PubMed ID: 28587057
[TBL] [Abstract][Full Text] [Related]
79. A systematic review of stereotactic radiotherapy ablation for primary renal cell carcinoma.
Siva S; Pham D; Gill S; Corcoran NM; Foroudi F
BJU Int; 2012 Dec; 110(11 Pt B):E737-43. PubMed ID: 23107102
[TBL] [Abstract][Full Text] [Related]
80. Polyvisceral gangrene due to radiation enteritis.
Wagholikar GD; Gupta RK; Kapoor VK
Trop Gastroenterol; 2002; 23(4):209-10. PubMed ID: 12833716
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
